HWAM
Hennion & Walsh Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,689
| Closed | -$239K | – | 860 |
|
|
2024
Q1 | $239K | Sell |
13,689
-2,062
| -13% | -$36K | 0.01% | 755 |
|
|
2023
Q4 | $148K | Sell |
15,751
-12,283
| -44% | -$116K | 0.01% | 793 |
|
|
2023
Q3 | $313K | Sell |
28,034
-2,380
| -8% | -$26.6K | 0.02% | 637 |
|
|
2023
Q2 | $651K | Sell |
30,414
-165
| -0.5% | -$3.53K | 0.04% | 445 |
|
|
2023
Q1 | $1.24M | Sell |
30,579
-750
| -2% | -$30.3K | 0.08% | 317 |
|
|
2022
Q4 | $1.46M | Sell |
31,329
-38,995
| -55% | -$1.81M | 0.09% | 263 |
|
|
2022
Q3 | $3.65M | Sell |
70,324
-7,096
| -9% | -$368K | 0.24% | 108 |
|
|
2022
Q2 | $3.66M | Sell |
77,420
-27,074
| -26% | -$1.28M | 0.23% | 120 |
|
|
2022
Q1 | $7.44M | Buy |
104,494
+2,430
| +2% | +$173K | 0.4% | 59 |
|
|
2021
Q4 | $7.63M | Sell |
102,064
-18,176
| -15% | -$1.36M | 0.37% | 63 |
|
|
2021
Q3 | $6.83M | Sell |
120,240
-4,140
| -3% | -$235K | 0.36% | 62 |
|
|
2021
Q2 | $5.47M | Buy |
124,380
+10,440
| +9% | +$459K | 0.29% | 81 |
|
|
2021
Q1 | $5.62M | Buy |
+113,940
| New | +$5.62M | 0.34% | 73 |
|